Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

March 30, 2015 8:49 PM ET


Company Overview of Genzyme Corporation

Executive Profile

James A. Geraghty J.D.

Interim Chief Business Officer, Voyager Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 6 Board Members in 6 different organizations across 11 different industries.

See Board Relationships


Mr. James A. Geraghty, also known as Jim, J.D., serves as Interim Chief Business Officer of Voyager Therapeutics, Inc. Mr. Geraghty has been an Entrepreneur-in-Residence at Third Rock Ventures, LLC since May 14, 2013. He serves as Director at Voyager Therapeutics, Inc. Mr. Geraghty served as Senior Vice President of North America Strategy and Business Development at Sanofi. He spent 20 years at Genzyme Corporation. Mr. Geraghty served as Vice President of Marketing and ...

Corporate Headquarters

500 Kendall Street
Cambridge, Massachusetts 02142

United States

Phone: 617-252-7500
Fax: 617-252-7600

Board Members Memberships

Former Director
Chairman and Member of Nominating & Corporate Governance Committee
Chairman of The Board and Member of Nominating & Corporate Governance Committee


The University of Pennsylvania
Georgetown University
Yale Law School

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Genzyme Corporation, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at